New nebulizer may ease chronic sinusitis symptoms
NCT ID NCT07270302
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests if a nebulized steroid (budesonide) delivered via the NasoNeb device is safe and effective for chronic rhinosinusitis. 50 adults with the condition will be randomly assigned to receive either nebulized budesonide or a standard steroid lavage. The main goal is to see if the nebulized version improves symptoms more, as measured by a sinus symptom questionnaire.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- budesonide
- What this could lead to
- If successful, this could offer a more effective way to deliver steroids to the sinuses, improving symptoms like congestion and facial pain.
- What could go wrong
- This is an early Phase 1/2 trial with only 50 participants, so results may not apply widely. The treatment may not work better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nyssa Fox Farrell
St Louis, Missouri, 63122, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple antiseptic rinse improve sinus surgery recovery?
- Melatonin may calm nerves before sinus surgery – study finds optimal dose
- New sinus test could change how we treat chronic sinusitis
- Sinus surgery showdown: crushing vs cutting for a common nose problem
- Sinusitis secrets: could a salt channel be the culprit?
- New antibody injection aims to tame stubborn sinusitis